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An unanticipated and tremendous amount of the noncoding sequence of the human genome is transcribed. Long noncoding
RNAs (lncRNAs) constitute a significant fraction of non-protein-coding transcripts; however, their functions remain
enigmatic. We demonstrate that deletions of a small noncoding differentially methylated region at 16q24.1, including
lncRNA genes, cause a lethal lung developmental disorder, alveolar capillary dysplasia with misalignment of pulmonary
veins (ACD/MPV), with parent-of-origin effects. We identify overlapping deletions 250 kb upstream of FOXF1 in nine
patients with ACD/MPV that arose de novo specifically on the maternally inherited chromosome and delete lung-specific
lncRNA genes. These deletions define a distant cis-regulatory region that harbors, besides lncRNA genes, also a differentially
methylated CpG island, binds GLI2 depending on themethylation status of this CpG island, and physically interacts with and
up-regulates the FOXF1 promoter.We suggest that lung-transcribed 16q24.1 lncRNAsmay contribute to long-range regulation
of FOXF1 by GLI2 and other transcription factors. Perturbation of lncRNA-mediated chromatin interactions may, in general,
be responsible for position effect phenomena and potentially cause many disorders of human development.
[Supplemental material is available for this article.]
Mammalian regulatory elements, including enhancers, repressors,
and insulators, are usually contained in genomic regions that lack
protein-coding genes and can be located hundreds of kilobases from
genes that they regulate (Birney et al. 2007). High-throughput anal-
ysis of the human transcriptome revealed that the majority of the
noncoding portion of the genome is transcribed as regulatory RNAs
(Khalil et al. 2009; Mattick 2010). Long noncoding RNAs (lncRNAs)
are non-protein-coding transcripts longer than 200 nt, distinguished
from small regulatory RNAs such as microRNAs, siRNAs, piRNAs,
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and snoRNAs. Little is known about the function of lncRNAs in
humans with XIST being the earliest identified and best character-
ized to date human lncRNA. Recently, lncRNAs have been impli-
cated in imprinting and long-range gene regulation with functional
properties of enhancers (Khalil et al. 2009; Mattick 2010;Wang and
Chang 2011). Here, we demonstrate that loss of a distant enhancer
region in a protein-coding gene desert at 16q24.1, which includes
lung-expressed lncRNA genes, leads to alveolar capillary dysplasia
with misalignment of pulmonary veins (ACD/MPV; MIM 265380).
ACD/MPV is a rare, neonatally lethal developmental disorder
of the lungs defined by malposition of pulmonary veins adjacent
to small pulmonary arteries, medial thickening of small pulmonary
arteries, deficient lobular development, a paucity of alveolar wall
capillaries, and occasional lymphangiectasis (Langston 1991; Bishop
et al. 2011). A few familial ACD/MPV cases have been described (Sen
et al. 2004, 2012; Eulmesekian et al. 2005). During the last 10 years,
we ascertained ACD/MPV samples (mainly formalin-fixed paraf-
fin-embedded lung tissues) from more than 90 families. In 2009, we
reported genomic deletions and inactivating point mutations in the
FOXF1 gene in chromosome 16q24.1 in unrelated patients with spo-
radic histopathologically verified ACD/MPV (Stankiewicz et al. 2009).
FOXF1 (Forkhead box protein F1) is a member of the FOX
transcription factor family sharing a winged helix/forkhead DNA-
binding domain (Lai et al. 1993; Pierrou et al. 1994; Kaestner et al.
2000). FOXF1 and itsmouse ortholog are predominantly expressed
in subepithelial mesenchymal tissues of developing lung and
foregut (Chang and Ho 2001; Mahlapuu et al. 2001a; Maeda et al.
2007; Bozyk et al. 2011). Homozygous mice deficient for Foxf1
die in utero by embryonic day 10 (E10) due to defects in mesoder-
mal differentiation and cell adhesion (Mahlapuu et al. 2001b). In-
terestingly,;50%of Foxf1+/mice died frompulmonaryhemorrhage
and showed severe defects in alveolarization and vasculogenesis
(Kalinichenko et al. 2001), partially recapitulating histopathological
pulmonary defects in infants with ACD/MPV, whereas the remainder
appeared normal.
Both in vitro and in vivo studies inmice have shown that none
of the in silico–predicted transcription factor binding sites located
within the Foxf1 promoter confer its tissue specificity (Chang and
Ho 2001; Kim et al. 2005), suggesting that the promoter is regulated
by tissue-specific distant regulatory elements. Also, deletions up-
streamof FOXF1, leaving FOXF1 intact, have been described in two
patients with ACD/MPV, suggesting the presence of distant regu-
latory elements for FOXF1 (Stankiewicz et al. 2009). In addition,
FOXF1 has been bioinformatically predicted to be paternally
imprinted (Luedi et al. 2007), and other studies have supported
this prediction (Stankiewicz et al. 2009; Sen et al. 2012).
We now report novel overlapping de novononcoding deletion
copy-number variants (CNVs) located 96–257 kb upstream of
FOXF1 in seven patients with ACD/MPV, who all died in the first
month of life with severe respiratory distress and pulmonary hy-
pertension. Based on extensive experimental characterization of the
microdeletion-defined upstream regulatory region, we propose that
paternally incompletely imprinted FOXF1 is regulated in cis by an
interplay between chromatin looping, possiblywith contribution of
lncRNAs, and methylation-controlled GLI2 binding.
Results
Noncoding deletion CNVs upstream of FOXF1
DNA samples from nine patients with ACD/MPV, negative for
point mutations within the FOXF1 coding exons, were analyzed
by array comparative genomic hybridization (aCGH) for the pres-
ence of CNVs in 16q24.1. In sample 59.4, aCGH revealed a 15-kb
deletion of the entire FOXF1 and its promoter. Studies of the re-
maining eight cases identified CNVs that left the FOXF1 coding
region intact. In patient 41.4, an;11-kb deletion, mapping 2.6 kb
upstream of FOXF1, removed one copy of the distal portion of
the FOXF1 promoter, corresponding to Foxf1 promoter region II
in mice (Kim et al. 2005) and overlapping with a portion of the
lncRNA gene FOXF1-AS1 (also known as lncFOXF1 [Khalil et al.
2009] and TCONS_00024240) (Ota et al. 2004). We show by RT-
PCR and DNA sequencing that FOXF1-AS1 is expressed in normal
human newborn lungs (Supplemental Fig. S1). In the remaining
seven patients, overlapping deletions, ranging in size from 140 kb
to 2625 kb, mapped 96–257 kb upstream of FOXF1 (Fig. 1; Sup-
plemental Table S1).
To better estimate the recurrence risk for these deletions, we
mapped and sequenced the deletion breakpoints of six of the up-
stream microdeletions (patients 57.3, 60.4, 64.5, 77.3, 95.3, and
96.3) (Supplemental Fig. S2; Supplemental Table S1) and the
microdeletion that included the FOXF1 gene (patient 59.4) (Sup-
plemental Fig. S2). Microhomology was identified in five of seven
breakpoint junctions (patients 57.3, 60.4, 64.5, 77.3, and 95.3),
consistent with the deletions arising by a template switching
replicative mechanism such as FoSTeS/MMBIR (Lee et al. 2007;
Hastings et al. 2009). In three of these five cases, both deletion
breakpointsmappedwithinAlu elements (Supplemental Table S1).
The probability of finding both breakpoints in Alu elements by
chance was estimated at less than 0.0066 (Supplemental Fig. S3),
thus being much lower than the observed frequency of finding
breakpoints of ACD/MPVmicrodeletions inAlu repetitive elements.
This finding suggests a mechanistic link between Alu sequences
and the location of microdeletion breakpoints. Interestingly, in
patients 64.5 and 95.3, the distal breakpoints were located within
the same copy of an AluSx element (;100 bp apart), thus defining
Figure 1. Nine (two published—D9, D10—and seven novel) ACD/
MPV-causing microdeletions share a 75-kb putative regulatory region
(SDR), mapping 257 kb upstream of FOXF1 (16q24.1). Array CGH plots of
two deletions defining SDR are shown.
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a potential breakage-prone hotspot. In patient 59.4, the breakpoints
occurred within highly homologous regions of the low-complexity/
GC-rich repeats and SINE/MIR repeats.We did not find any evidence
for low-level somatic mosaicism in parental blood samples using
PCR for patient-specific junction fragments; all microdeletions ap-
pear to have occurred de novo (Supplemental Fig. S4).
Regulatory region upstream of FOXF1
Sequence alignments of the seven distant microdeletions
showed that they share a 75-kb region 257 kb upstream of FOXF1
(chr16:86,212,040–86,287,054; shared deletion region, SDR) (Fig.
1; Supplemental Table S1). We found that the SDR represents
a protein–gene desert (http://genome.ucsc.edu). Nevertheless, this
genomic region harbors DNA segments that are evolutionarily
conserved among land vertebrates and have high 73 regulatory
potential (Fig. 2A). Hence, we hypothesized that the SDR may
contain regulatory site(s) controlling the FOXF1 promoter.
Interestingly, we also found that the SDR encompasses one
locus (chr16:86,223,827–86,234,547) and part of another locus
(chr16:86,254,429–86,338,058), encoding differentially spliced pu-
tative lncRNAs exhibiting increased expression in the lungs (http://
genome.ucsc.edu). The 43.5-kb ESTCR737045 (chr16:86,259,186–
86,302,689), part of the 79-kb lncRNA TCONS_00024764, is spe-
cifically expressed in fetal lungs (SOURCE at http://source.stanford.
edu). We show, by RT-PCR and sequencing, that TCONS_00024764
lncRNA gene is also expressed in normal newborn lung at a much
higher level than in HEK293 kidney cells and lymphoblasts (Sup-
plemental Fig. S1).
We further narrowed SDR to ;10-kb Segment 1 of the highest
73 regulatory potential and sequence conservation (Fig. 2A), con-
taining a cluster of the predicted binding sites for theGLI1, GLI2, and
GLI3 transcription factors (GLI-binding sites, consensus sequence:
GACCACCCACNNNG [Hallikas et al. 2006]) overlapping with a
CpG island (Fragment 1a) (Fig. 2B; Supplemental Fig. S5), and;8-kb
Segment 2 with multiple binding sites for other transcription regu-
lators, and the highest potential for histone methylation and acetyla-
tion. Both segments encode lncRNAs expressed in the lungs (Fig. 2A).
GLI2 binds within the upstream regulatory region
Sonic hedgehog (SHH) signaling targets a GLI2 transcription factor
and is crucial for early lung development in mice (Rutter et al.
2010) and humans (Zhang et al. 2010). GLI1-3 have been shown to
be expressed in human lung mesenchymal tissues, including
endothelial cells (Maeda et al. 2007). Moreover, studies in mice
have shown that Gli2 regulates Foxf1 expression in the de-
veloping stomach and intestine (Madison et al. 2009), which,
together with airway and alveolar tissues, are of endodermal or-
igin. To determine whether in silico–identified GLI-binding sites
in the SDR bind GLI2 in vivo, we screened the SDR for the GLI2
binding using a ChIP-chip assay. We detected strong binding of
GLI2 to SDR in the cultured human pulmonary microvascular
endothelial cells (HPMEC) (p = 0.007, n = 2) at a region including
several in silico–predicted GLI-binding sites (chr16:86,232,498–
86,232,882) (Supplemental Figs. S5, S6). Although only one of
the GLI-binding sites of SDR perfectly matches the consensus
sequence, the clustering of nine of these sites within a 0.2-kb
portion of Fragment 1a may have a synergistic effect on GLI2
binding. Given that HPMEC expresses both FOXF1 and GLI2
(Supplemental Fig. S7), we hypothesized that GLI2 binding at
SDR may regulate FOXF1 transcription.
GLI2 binding to the distant enhancer regulates FOXF1
promoter
To this end, we performed a secreted alkaline phosphatase (SEAP)
reporter assay in HPMEC (Fig. 3A,B). We prepared plasmid con-
structs that allow for transient expression of the SEAP reporter gene
under the control of the FOXF1 promoter and its putative regula-
tory sites. The upstream putative regulatory sequences were then
tested both in cis (inserted into a vector upstream of the FOXF1
promoter) and in trans (placed on another plasmid used in the
cotransfection of HPMEC with the FOXF1 promoter–containing
reporter vector). The 5.5-kb FOXF1 promoter region includes
two intervals that remain highly conserved between mice and
humans (Kim et al. 2005) and contains, besides the RNA Pol II–
binding site (chr16:86,543,198–86,543,374), multiple transcrip-
tion factor binding sites (http://genome.ucsc.edu). When placed
upstream of the promoterless SEAP, the 5.5-kb promoter region
activated SEAP transcription 11-fold to 20-fold; this range depended
on whether the cells were additionally cotransfected with a
pCS2Gli2 vector, constitutively expressing GLI2 (P < 0.0001)
(Fig. 3A). Madison et al. (2009) demonstrated that the FOXF1
promoter harbors the evolutionarily conserved (identical among
mammalian, bird, fish, and amphibian species) consensus GLI-
binding site (chr16:86,539,377–86,539,385) that is deleted in pa-
tient 41.4 (Fig. 1). As expected, the truncated version of the FOXF1
promoter, missing this GLI-binding site, showed weaker SEAP ex-
pression in comparison with the intact promoter, especially in
excess of GLI2 (P = 0.038) (Fig. 3A). Of note, several variant GLI-
binding sites are still present in the residual truncated promoter
region from case 41.4, potentially explaining why it responded,
although weakly, to an excess of GLI2 (Fig. 3A). Placement of the
0.6-kb part of Fragment 1a of the SDR, containing GLI-binding
sites, upstream of the FOXF1 promoter increased SEAP expression
from the FOXF1 promoter twofold (P < 0.0016). Activation of the
promoter by the SDR GLI-binding sites in trans also increased re-
porter expression (P = 0.027) (Fig. 3B), further suggesting that these
GLI-binding sites can regulate FOXF1 transcription from a distant
location, likely through chromatin looping that juxtaposes
FOXF1 promoter and SDR. Moreover, cotransfection of HPMEC
with the plasmid pCS2Gli2, constitutively expressing GLI2 pro-
tein, increased expression of the SEAP reporter from the FOXF1
promoter in all construct combinations that we tested (Fig. 3A,B),
further indicating that FOXF1 can be regulated in lung endo-
thelial cells by a GLI2 transcription factor. The increase of FOXF1
transcription from the 5.5-kb FOXF1 promoter alone, in re-
sponse to the extra GLI2 synthesis, most likely results from
binding of GLI2 to the mentioned consensus GLI-binding site or
any of several GLI-binding site variants located within 5.5 kb
upstream of FOXF1.
Using the SEAP reporter assay, we also tested an in silico–
identified putative regulatory Segment 2, located;16 kb distally to
the Segment 1 (Fig. 2A). This region was indicated by ChIP-seq
assays to bind CTCF and several transcription factors other than
GLI2 (http://genome.ucsc.edu). In the presence or absence of ex-
cess GLI2, a 1.4-kb fragment (chr16:86,256,619–86,258,038) of
Segment 2 appeared to have no effect on the SEAP expression from
the FOXF1 promoter when subcloned next to the FOXF1 promoter
in the same orientation as the promoter, but increased the pro-
moter activity fivefold when placed in the opposite orientation
(P < 0.0001) (Fig. 3A). When tested in trans, the 1.4-kb fragment of
Segment 2 did not significantly affect the FOXF1 promoter activity
(Fig. 3B). Thus, in contrast to the GLI-binding sites of Fragment 1a,
Long-range regulation paternal imprinting of FOXF1
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Figure 2. Characterization of the SDR. (A) Segment 1 (;10 kb; black rectangle) and Segment 2 (;8 kb; red rectangle), harboring, among others,
transcription factor binding sites and a part of the fetal lung–expressed lncRNA gene, are shown. The figure is drawn according to the 2009 Human
Reference Sequence (GRCh37/hg19). (B) Insight into the;1.5-kb Fragment 1a showing (from top to bottom) the bisulfite sequenced region, methylation
array oligo probes (red arrows) that indicate differential methylation, differentially methylated CpG island, ChIP-chip GLI2-binding region, 73 regulatory
potential, mammalian evolutionary conservation, and CG content.
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Figure 3. Distant regulatory region, SDR, controls the activity of the FOXF1 promoter. (A,B) Results of the reporter assay experiments showing regu-
lation of the FOXF1 promoter in HPMEC by fragments of Segments 1 and 2 of the SDR. (FOXF1p) FOXF1 promoter (0–5.5 kb upstream of ATG codon)
cloned in pSEAP2Basic; (41.4delp) truncated FOXF1 promoter (0 to3.0 kb, ACD case 41.4) cloned in pSEAP2Basic; (Seg1FOXF1p) distant upstream GLI-
binding region (part of Fragment 1a) and FOXF1 promoter cloned in pSEAP2Basic; (Seg2>FOXF1p) Segment 2 putative enhancer and FOXF1 promoter
cloned in pSEAP2Basic in the same orientation; Seg2<FOXF1p, the same enhancer in reverse orientation and FOXF1 promoter cloned in pSEAP2Basic;
(vect) pGEM-T Easy vector; (Seg1) GLI-binding region of Fragment 1a cloned in pGEM-T Easy; (Seg2) putative enhancer of Segment 2 cloned in pGEM-T
Easy. The presence of additional GLI2, constitutively expressed from the pCS2Gli2 vector, is denoted by +GLI2. The GLI-binding region of Fragment 1a
stimulates activity of the FOXF1 promoter in cis (A) and in trans (B) settings. (C ) Results of the 4C experiment revealing long-range physical interaction
between the FOXF1 promoter and SDR. Coordinates of the SDR region interacting with the FOXF1 promoter (SDR-promoter interaction peaks) in HPMEC
are (from top) 86,246,725–86,246,982 (0.05 < FDR # 0.1) and 86,246,125–86,246,982 (0.1 < FDR # 0.2). The two HPMEC panels represent results of
independent experiments. No SDR-FOXF1 promoter interaction peak was detected in lymphoblasts, which do not express FOXF1.
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the tested fragment of Segment 2 seems unlikely to contribute to
the long-range control of the FOXF1 expression.
SDR–FOXF1 promoter chromatin looping
\To determine whether there is a physical interaction between
the FOXF1 promoter and the SDR that would juxtapose distant
GLI-binding sites and the FOXF1 promoter, we performed
a chromosome conformation capture-on-chip (4C) analysis. We
detected interactions between the FOXF1 promoter region and
regions located upstream of it, including the 75-kb SDR (Fig. 3C).
Using two independently prepared 4C libraries from HPMEC,
we identified overlapping SDR fragments (chr16:86,246,725–
86,246,982 and 86,246,125–86,246,982) interacting with the
FOXF1 promoter fragment (chr16:86,542,571–86,543,312) con-
taining part of the Pol II–binding site that were not detected in
the 4C library prepared from control lymphoblasts (Fig. 3C).
These SDR fragments map 12 kb distal to Segment 1. Chromatin
looping between SDR and the FOXF1 promoter could occur with
a contribution of lncRNAs (Mattick 2009, 2010; Ørom et al. 2010;
Wang and Chang 2011), including any of those encoded within
SDR. Moreover, CTCF binding within the SDR (Supplemental Fig.
S8) alsomight contribute to the formation of looping architecture
(Phillips and Corces 2009). Since we did not detect interactions
between SDR and the FOXF1 promoter in lymphoblasts, we
propose that chromatin looping between SDR and the FOXF1
promoter (Supplemental Fig. S9) allows GLI2 to increase FOXF1
activity specifically in lung endothelium and other tissues of
similar origin.
Maternal origin of ACD/MPV
microdeletions
We have determined parental origin for
seven out of eight upstream microdele-
tions (patients 57.3, 60.4, 64.5, 77.3,
81.3, 95.3, and 96.3) and for one micro-
deletion (59.4) that included the entire
FOXF1. Interestingly, all these micro-
deletions arose de novo on the maternal
chromosome (Supplemental Tables S1,
S2). Six published de novo microdele-
tions that included FOXF1 (D1, D3, D4,
and D8) or mapped upstream of FOXF1
(D9 and D10) also arose de novo on the
maternal chromosome (Stankiewicz et al.
2009). Moreover, in a recently published
unique familial case of ACD/MPV, with
missense mutations in FOXF1 affecting
five subjects, the mutation was inherited
from a heterozygous healthy mother, in
whom the mutation arose de novo on her
paternal chromosome (Sen et al. 2012). In
aggregate, these findings strongly suggest
a parental-origin bias of FOXF1-associated
CNVs (P < 0.001, n = 14).
Differential expression of FOXF1 parental
alleles
To further test whether FOXF1 is im-
printed, we compared FOXF1 expression
levels from both parental chromosomes using two sets of semi-
quantitative RT-PCRs with primers designed to differentiate be-
tween the two parental chromosomes. We found that whereas
both primer sets amplified equal amounts of FOXF1 from genomic
DNA, their amplification from cDNA differed by 27% (P = 0.011,
n = 3) (Supplemental Fig. S10). Thus, our data indicate that FOXF1
expression from the maternal chromosome is not equal to its
expression from the paternal chromosome, further indicating
that FOXF1 is imprinted in humans albeit incompletely.
Differentially methylated CpG site within SDR
Genomic imprinting can be caused by differential methylation of
CpG islands, histone modification, or interactions with lncRNAs
(Bartolomei 2009). Here, we have investigated in detail CpG meth-
ylation as one of the potential mechanisms of FOXF1 imprinting.
The FOXF1 promoter resides within a large CpG island (Lo et al.
2010). We have bisulfite-sequenced this region of DNA from normal
lung and have found that the FOXF1 promoter is not methylated
(Fig. 4A). Previous studies using immortalized normal mammary
cells and organoids have also shown that the FOXF1 promoter is
not methylated (Lo et al. 2010). Interestingly, the part of the
FOXF1 CpG island that is included in the FOXF1 first exon is
extensively methylated (Fig. 4A); however, the functional signifi-
cance of this methylation remains unknown. We also analyzed the
results of themethylation studies using Infinium450Kmethylation
arrays on 39 brain DNA samples from normal individuals (courtesy
of Dr. A.L. Beaudet). One of the 13 potentially differentially meth-
ylated regions upstream of FOXF1 encompassed three probes
Figure 4. Methylation of the SDR CpG island decreases SDR potential to activate the FOXF1 pro-
moter. (A) Methylation status of the FOXF1 promoter and SDR CpG island in normal fetal lung
(a similar CpG methylation pattern was observed in DNA isolated from blood). Each lane represents
a separate clone. (•) Methylated CpGs, (s) unmethylated CpGs. (Pink) Location of a cluster of
GLI-binding site variants. (Red) Position of the consensus ‘‘core’’ GLI-binding site. Genomic co-
ordinates of the bisulfite sequenced regions are: chr16:86,232,367–86,232,979 (SDR CpG island);
chr16:86,542,223–86,542,807 (FOXF1 promoter 2); chr16:86,543,777–86,543,907 (FOXF1 pro-
moter 1); chr16:6,544,458–86,545,037 (FOXF1 exon 1). (B) Dependence of the FOXF1 promoter
activity on the methylation status of the SDR CpG island. The presence of additional GLI2 constitu-
tively expressed from the pCS2Gli2 vector is denoted by +GLI2. (FOXF1p) FOXF1 promoter cloned in
pSEAP2Basic; (vect) pGEM-T Easy; (Seg1) GLI-binding region (Fragment 1a) cloned in pGEM-T Easy;
(mSeg1) GLI-binding region of Fragment 1a with in vitro–methylated CpG island cloned in pGEM-T
Easy; (Seg1*) mock control for mSeg1.
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located within the SDR Fragment 1a in the vicinity of a cluster of
GLI2-binding sites (Fig. 2B; Supplemental Fig. S5; Supplemental
Table S3) identified in the ChIP-chip experiment and function-
ally verified in the reporter assay. Bisulfite sequencing of the SDR
0.2-kb CpG island closest to the consensus GLI2-binding site and
overlappingwith several GLI-binding site variants confirmed that
it is differentially methylated in the DNA from normal fetal lung
(Fig. 4A).
Methylation of CpG island regulates GLI-binding sites
We were interested to know whether methylation of the CpG
island, including and neighboring the GLI-binding sites, interferes
with the ability of these sites to regulate FOXF1 expression. To this
end, we have methylated (in vitro) half of the C residues of this
CpG island in a 0.6-kb portion (chr16:86,232,261–86,232,908) of
Fragment 1a. We then cotransfected the methylated construct
with a FOXF1 promoter-harboring reporter plasmid. We observed
a reduction in the ability of the Fragment 1a GLI-binding sites to
activate the FOXF1 promoter, following partial methylation of
the CpG island (P = 0.015) (Fig. 4B). The function of the methyl-
ated GLI-binding region did not significantly increase in the
presence of excess GLI2 following the cotransfection of HPMEC
with pCS2Gli2 (Fig. 4B).
Discussion
We identified overlapping deletions located upstream of FOXF1 in
seven unrelated patients with ACD/MPV, defining a putative dis-
tant regulatory region (SDR) for FOXF1. This region, located 257 kb
59 to FOXF1, is 75 kb in size and contains two smaller segments
that are distinguished by high evolutionary conservation among
land vertebrates and high 73 regulatory potential (Fig. 2). The
;1.5-kb part of Segment 1 (Fragment 1a) encompasses several GLI-
binding sites (Supplemental Fig. S5). GLI2 is essential for lung
development in humans and mice (Maeda et al. 2007; Madison
et al. 2009; Rutter et al. 2010; Zhang et al. 2010). Using a ChIP-chip
assay, we have confirmed binding of GLI2 to Fragment 1a in
HPMEC (Supplemental Fig. S6). The 0.6-kb GLI2-binding portion
of Fragment 1a significantly increased transcription from the
FOXF1 promoter in our reporter assay, further indicating that it
may regulate FOXF1 in vivo (Fig. 3A,B). The increase of FOXF1
transcription occurred not only in cis but also in trans, suggesting
that this activation could occur in vivo through chromatin looping
that juxtaposes the FOXF1 promoter and SDR. The CTCF binding
within the SDR (Supplemental Fig. S8) may contribute to the for-
mation of this looping architecture (Phillips and Corces 2009).
Both cis and trans activations of the FOXF1 promoter seem to be
specific, since (1) substitution of the 0.6-kb sequence from the
1.5-kb Fragment 1a with a 1.4-kb fragment of Segment 2, harbor-
ing sites for transcription factors other than GLI2, in trans or in cis
in its original genomic orientation had no effect on the promoter
activity; and (2) the 3-kb empty vector pGEM-T Easy did not acti-
vate the FOXF1 promoter.
We supported the chromatin looping hypothesis via 4C
studies, in which we identified physical interaction of the SDR
with the FOXF1 promoter close to the Pol II–binding site (Fig. 3C).
This interaction brings the distant GLI2-binding sites to the
proximity of the FOXF1 promoter. Although only one of the dis-
tant GLI-binding sites of SDR perfectly matches the consensus
‘‘core’’ sequence, the clustering of nine of these sites within this
segment may have synergistic effects on GLI2 binding. Moreover,
the variant GLI-binding sites with relatively low affinity have been
recently shown to strongly induce transcription when present in
native promoters (Winklmayr et al. 2010). Since we did not detect
interactions between SDR and the FOXF1 promoter in lympho-
blasts, where FOXF1 is not expressed, we propose that chromatin
looping between SDR and FOXF1 allows GLI2 to increase FOXF1
activity specifically in lung endothelium.
Importantly, we have also identified putative lncRNA genes
within the SDR region (Fig. 2A). LncRNAs play a crucial role in
embryonic development (Ulitsky et al. 2011). Moreover, lncRNAs
have been proposed to play a role in imprinting and both in cis and
in trans regulation of gene expression by acting as scaffolds for
chromatin-modifying complexes and nuclear bodies, as en-
hancers as well asmediators of long-range chromatin interactions
(Guttman et al. 2009;Mattick 2009, 2010;Nagano and Fraser 2011;
Wang and Chang 2011). Thus, it seems tempting to speculate that
some of the lung-expressed lncRNAs may be needed for tissue-
specific interaction of the FOXF1 promoter with the distant regu-
latory regions. LncRNAs can also guide chromatin-modifying
complexes to specific genomic loci to regulate gene expression
(Mattick 2010). For instance, Khalil et al. (2009) showed that a 34-
kb lncRNA FOXF1-AS1, mapping 1.7 kb upstream of FOXF1, binds
the Polycomb repressive complex PRC2. Of note, this lncRNA has
the highest expression in human lungs (http://genome.ucsc.edu)
(see also Supplemental Fig. S1) and partially overlaps with the
FOXF1 promoter, and its locus is largely deleted in the ACD/MPV
case 41.4. Our preliminary experiments on FOXF1-AS1 knock-
down using siRNAs showed that ;50% decrease of FOXF1-AS1
expression in HPMEC resulted in a weak increase of FOXF1 tran-
scription (Supplemental Fig. S1), supporting its suggested function
as a transcriptional repressor (Khalil et al. 2009). However, in case
41.4, in addition to the FOXF1-AS1 gene, a GLI-binding consensus
sequence is also deleted, likely leading to a net decrease of FOXF1
expression.
Intriguingly, all of the deletions for which we were able to
determine the parental chromosome origin arose on maternal
chromosome 16, strongly suggesting that FOXF1 could be pater-
nally imprinted (P < 0.001, n = 14). The paternal imprinting of
FOXF1 has been also predicted bioinformatically (Luedi et al. 2007).
Even so, any paternal imprinting is probably incomplete, because
paternal uniparental disomy of chromosome 16 (UPD16pat) has
been reported in a child with only prenatal and postnatal growth
retardation (Kohlhase et al. 2000). Our data showing differential
expression of FOXF1 in the lungs support a partial imprinting
hypothesis (Supplemental Fig. S10). We also reported a paternally
inherited no-stopmutation (last codon) in FOXF1 in a patientwith
ACD/MPV (Stankiewicz et al. 2009). We hypothesize that the
extended FOXF1 RNA transcript might have escaped nonsense-
mediated decay and negatively interacted with the wild-type copy,
resulting in ACD/MPV.
Wehave investigated in detail CpGmethylation as a potential
mechanism of FOXF1 imprinting. The FOXF1 promoter resides
within a large CpG island (Lo et al. 2010), which is not methylated
in normal lung tissue (Fig. 4A). Using genome-wide differential
methylation array hybridization and bisulfate sequencing, we
found that a small CpG island, located within Fragment 1a of SDR
and overlapping with GLI-binding sites, is differentially methyl-
ated. Using in vitro methylation and reporter assays, we showed
that the methylation of this distant CpG island compromises the
ability of its GLI-binding region to activate the FOXF1 promoter in
vitro (Fig. 4B). Although only two of the GLI-binding site variants
includeCpGswithin their sequence and thus canbedirectly affected
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byCpGmethylation, it is likely thatmethylation of theCpG island
changes the local DNA environment, resulting in the decrease of
affinity of its GLI-binding sites for GLI2. Interestingly,methylation
of CpGs has been also shown to inhibit interaction with DNA of
the GLI-type zinc-finger factor YYI (Kim et al. 2003).
Position effect or cis-ruption disorders are defined as condi-
tions arising due to disruption of the cis regulatory genomic ar-
chitecture of a disease gene locus (Kleinjan and van Heyningen
2005; Kleinjan and Coutinho 2009). To date, this phenomenon
has been reported for more than 40 genetic loci in the human
genome; however, the underlying mechanism remains unknown.
Of interest, a 7.4-kb cis-regulatory deletion disrupting conserved
noncoding sequences and their interaction with the promoter of
another FOX gene, FOXL2, mapping more than 280 kb apart, has
been described as pathogenic for blepharophimosis, ptosis, and
epicanthus inversus (BPES, OMIM 110100) (D’haene et al. 2009).
In addition, genomic deletions and an apparently balanced trans-
location breakpoint mapping over 250-kb downstream from
FOXG1 have been reported in patients with a congenital variant
Rett syndrome (OMIM 613454) (Kortu¨m et al. 2011; Ellaway et al.
2012), suggesting that also other FOX genes may be regulated by
long-range chromatin cis-interactions. Recently, Guttman et al.
(2011) successfully knocked down genome-wide 147 (out of 226)
lncRNAs using shRNAs and observed gene dysregulation both in
trans and cis, with cis effects ranging up to 300 kb. Our findings
further suggest that lncRNA-controlled gene regulation could be
responsible for the position effect phenomenon in humans and
potentially cause many other disorders of development.
In summary, we propose a model of long-range regulation of
FOXF1 expression in the lungs that includes CpG methylation-
controlledGLI2 binding at a distant tissue-specific enhancer, whereby
chromosomal looping, likely mediated by lncRNAs and/or CTCF,
juxtaposes this enhancer and the FOXF1 promoter.
Methods
Subject recruitment
DNA samples were collected from nine unrelated probands clini-
cally and histopathologically diagnosed with ACD/MPV. All pa-
tients died from severe pulmonary insufficiency and hypertension
in the first month of life.
DNA and RNA isolation, and DNA sequencing
Peripheral blood DNA was extracted using the Gentra Puregene
Blood Kit (QIAGEN). DNA from frozen lung tissues was extracted
using the DNeasy Blood & Tissue Kit (QIAGEN). DNA from FFPE
lung tissues was isolated following the manufacturer’s protocol
(Agilent Technologies). RNA from cultured HPMEC was extracted
using the RNeasy Protect Mini Kit (Invitrogen). Lung RNA was
isolated from frozen tissues using the Illustra TriplePrep Kit (GE
Healthcare).
PCR products and plasmid DNAwere sequenced by the Sanger
method (Lone Star Labs). Before cycle sequencing, PCR products
were treated with ExoSAP-IT (USB) to remove unincorporated nu-
cleotides and primers.
DNA sequence analysis
Reference sequences were downloaded from the UCSC Genome
Browser (NCBI build 37/hg19; http://genome.ucsc.edu). DNA
sequence similarities were analyzed using BLAT (http://genome.
ucsc.edu). Evolutionary conservation and regulatory potential of
the analyzed sequences were assessed using the UCSC ‘‘Conser-
vation’’ and ‘‘73 Reg potential’’ tracks, respectively. The 73 reg-
ulatory potential scores are computed from alignments of hu-
man, chimpanzee, macaque, mouse, rat, dog, and cow genomes
using log-ratios of transition probabilities from two variable order
Markov models (Kolbe et al. 2004; King et al. 2005). Sequences
were assembled using Sequencher v4.8 (GeneCodes). Repeti-
tive sequences were identified using RepeatMasker (http://
repeatmasker.org). GC content was determined using CpGPlot
(http://ebi.ac.uk/Tools/emboss/cpgplot). CTCF-binding hotspots
were identified using the University of Washington CTCF bind-
ing site track from the UCSC Genome Browser (ChIP-Seq deter-
mined) using a threshold value of 500. P-values of finding
microdeletion with both breakpoints in Alu family repetitive
elements by chance were calculated using an approach similar to
the one presented by de Smith et al. (2008) (see also Supple-
mental Methods).
Screening FOXF1 for mutations
The entire coding region of FOXF1 (two exons) and its splicing
sites were amplified for each patient in partially overlapping
fragments using GoTaq Flexi DNA Polymerase (Promega) in the
presence of 8% DMSO. The PCR conditions were 25 cycles of
incubation for 30 sec at 94°C, 30 sec at 56°C, and 30 sec at 72°C.
Following purification, PCR products were directly sequenced.
DNA sequences were then compared with the FOXF1 reference
sequence (NM_001451.2).
Genomic copy-number analysis
CNVs were identified by aCGH with either custom-designed
16q24.1 region-specific (1 Mb flanking FOXF1) 180K oligonucle-
otide microarrays (Agilent Technologies) or 4.2M genome-wide
oligonucleotide microarrays (Roche-NimbleGen). 43180 micro-
arrays were scanned using an Agilent DNA Microarray Scanner,
and the data were analyzed using Agilent Genomic Workbench
software. 4.2M microarrays were scanned on a Roche-NimbleGen
MS 200 Microarray Scanner. Scanned images of the arrays were
processed using NimbleScan v2.5 (Roche NimbleGen) and ana-
lyzed using SignalMap v1.9 (Roche NimbleGen).
Amplification and sequencing of microdeletion breakpoints
PCR primers flanking each microdeletion (Supplemental Table S4)
were designed using Primer3 v0.4.0 software (http://frodo.wi.mit.
edu/primer3/). Amplification of 5- to 12-kb junction fragments
for sequencing was performed using LA Taq polymerase (TaKaRa
Bio USA).
Parental origin of microdeletions
Parental origin of microdeletions was determined following iden-
tification of informative SNPs in parental and patients’ chromo-
somes. Regions containing the potentially informative SNPs were
amplified by PCR and directly sequenced. The primers used in this
analysis were designed based on the location of known SNPs.
ChIP-chip analysis
Chromatin immunoprecipitation with anti-GLI2 antibody was
conducted in HPMEC (ScienCell Research Laboratories). Expres-
sion of FOXF1 and GLI2 in these cells was confirmed by RT-PCR
using the SuperScript One-Step RT-PCR Kit (Invitrogen) (Supple-
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mental Fig. S7; Supplemental Table S5). The reference DNA was
extracted from skin fibroblasts that do not express FOXF1. HPMEC
were cultured to confluence in EMS medium supplemented with
10% FBS, ECGS, and 1% penicillin-streptomycin (ScienCell Re-
search Laboratories) at 37°C with 5% CO2. Fibroblasts were cul-
tured in DMEM medium (Invitrogen), supplemented with 10%
FBS and 1% penicillin–streptomycin, at 37°C with 10% CO2. Be-
cause of low levels of endogenous GLI2 expression, cells were
transfected, 24 h before the assay, with GLI2-expressing plasmid
pCS2Gli2 (Roessler et al. 2005) (Addgene) (1 mg of DNA/60-mm
plate) using Lipofectamine LTX and Plus Reagent (Invitrogen).
Protein–chromatin interactions were captured by incubating cells
with 1% formaldehyde for 10min at room temperature. Cells were
then lysed in SDS lysis buffer and sonicated. Fragmentation of the
DNA to ;1-kb fragments was verified by agarose gel electropho-
resis. Immunoprecipitation was performed using an EZ ChIP kit
(Millipore) and anti-GLI2 antibody (R&D Systems). Five microli-
ters of the anti-GLI-2 antibody was added to 1 mL of the sample,
and the GLI2–DNA complex was immunoprecipitated over-
night at 4°C. Twenty microliters of Normal Sheep IgG (R&D
Systems) was used as a negative control. Anti-mono/di/tri
methyl-histone H3 (lys4) clone AW304 rabbit monoclonal IgG
(Upstate) was used as a positive control. The MinElute PCR Pu-
rification Kit (QIAGEN) was used to purify and concentrate DNA
to a final volume of 10 mL. Immunoprecipitated DNA was then
amplified using the GenomePlex Complete Whole Genome
Amplification Kit (Sigma-Aldrich). After amplification, samples
were labeled with Cyanine dUTP (Agilent Technologies) using
the Agilent Genomic DNA Enzymatic Labeling Kit and used for
array hybridization for 24 h at 65°C on a custom-designed
16q24.1-region-specific 4x180K oligonucleotide microarray
(Agilent Technologies).
Reporter assay constructs
The 5.5-kb FOXF1 promoter region (chr16: 86,538,679–
86,544,175), directly upstream of the FOXF1’s AUG initiation
codon, was amplified by PCR from genomic DNA isolated from
the blood sample of a normal control individual. This region
contained the entire 43-bp-long 59-untranslated part of the FOXF1
first exon. The primers used for the amplification were Foxp2F2: 59-
CTAGCTAGCACATTTCCTCATATTCTGTGTAGAGAGCACCT-39 and
FoxAUG2R: 59-TTGCGCCGATTCGAACGGGTGGCTGCTG-39, and
included restrictions sites for NheI and BstBI, respectively. PCRwas
done using LATaqDNApolymerase (TaKaRa Bio) in the presence of
6%DMSO, applying 25 cycles of 30 sec at 94°C and 5min at 68°C.
Following digestion with NheI and BstBI (NEB), the PCR product
was cloned between NheI and BstBI sites of the multiple clon-
ing site of the promoterless SEAP reporter vector, pSEAP-Basic
(Clontech), generating a plasmid, p5.5FoxSEAP. The pSEAP2-Control
vector, containing the constitutive SV40 early promoter with its
enhancer, was used as a positive control in the assay. The plasmid
p41.4D4, containing the truncated version of the 5.5-kb FOXF1
promoter region (devoid of its 59 portion deleted in an ACD/MPV
case 41.4) was constructed by digesting the p5.5FoxSEAP with
KpnI and relegating the remaining portion of the vector. A
0.6-kb portion of Fragment 1a (chr16:86,232,261–86,232,908),
bearing CpG island and GLI2-binding sites, was amplified from
genomic DNA of a normal control individual using Taq DNA
polymerase (Invitrogen) and the following primers: upsdelCGliF:
59-GTGCTAGCATGGTGTAAATCACCCTGACAGTAAACACT-39 and
upsdelCGliR1: 59-GTGCTAGCGATCTATTCTGCTATCTACCCTCT
GCTTTTCC-39, both encompassing the NheI site. PCR conditions
were 25 cycles of 30 sec at 94°C, 30 sec at 58°C, and 1 min at
72°C. This 0.6-kb fragment was then cloned both into pGEM-T
Easy (Promega) by T-vector cloning to create pGliTEasy, and,
following digestion with NheI, into the NheI site of p5.5FoxSEAP,
upstream of the 5.5-kb FOXF1 promoter region, generating pGli-
5.5FoxSEAP. The 1.4-kb putative enhancer region of Segment 2
(chr16:86,256,619–86,258,038) was amplified by PCR using Pfu
Ultra DNA polymerase (Stratagene) with the primers upsdelEnhF:
59-AAACTTCATCTCTCCCTGCAGCTTCTCTGT-39 and upsdelEnhR:
59-GTTGGACTCTGAAATCAGTGCCTTCAACAT-39. The blunt-ended
PCR product was A-tailed using GoTaq Flexi DNA polymerase and
cloned in the pGEM-T Easy vector to generate plasmid pEnhTEasy.
This new vector was then cut with NheI, and the putative en-
hancer-containing fragment was subcloned in the NheI site of
p5.5FoxSEAP, generating the plasmid pEnh5.5FoxSEAP.
Cell transfection and reporter assay
The HPMEC were cultured as described above. Transient trans-
fection of HPMEC with reporter gene constructs was done by
electroporation using the NEON transfection system (Invitrogen).
The electroporation parameters were as follows: pulse voltage,
1350 V; pulse width, 30 msec; pulse number, 1; cell density, 1.0 3
107 cells/mL. The transfection efficiency was between 20%
and 30%. One-half microgram of pSEAP2Basic (no promoter),
pSEAP2Control (Clontech), pEnhTEasy, pUpstdelGliTEasy, or
1 mg of p5.5FoxSEAP, pGli5.5FoxSEAP, or pEnh5.5FoxSEAP was
cotransfectedwith 0.1mg of pMetLuc-Control (Clontech) (internal
control for transfection efficiency) and with or without 0.4 mg
of pCS2Gli2 in 24-well plate setting.
In an in vitro methylation experiment, 3 mg of linearized,
methylated, or nonmethylated pUpstdelGliTEasy vector was
cotransfected with p5.5FoxSEAP and pMetLucControl. One set
of transfections included also pCS2Gli2. Eachwell of 24-well plates
was seeded with 1.5 3 105 cells. Activities of SEAP and Metridia
luciferase (MetLuc) were measured 55 h later by a luminescence
assay using the Ready-to-Glow Dual Secreted Reporter System
(Clontech) according to the manufacturer’s protocol. Lumines-
cence was recorded using microplate LUMIstar Omega lumino-
meter (BMG Labtech). SEAP activities of individual transfections
were normalized forMetridia luciferase activities. Results are shown
as the mean of three independent experiments. Statistical signif-
icance of the observed differences was estimated applying an
unpaired t-test.
4C analysis
3C libraries were generated according to the protocol described by
Dostie and Dekker (2007) using 1 3 107 HPMEC or lymphoblasts.
Cross-linked DNA was digested with EcoRI overnight, and religated
with T4 ligase for 4 h at 16°C at low DNA concentration. The 3C
library was then processed according to the procedure described by
Simonis et al. (2007). The ligation junctions were trimmed by di-
gestion of 3C library with TaqaI overnight, followed by phenol:
chloroformextraction, religation at lowDNAconcentration for 4 h at
16°C, andDNA linearization with HindIII overnight at 37°C. The 4C
template was created by linear amplification of DNA using the Ex-
pand Long Template PCR System (Roche Applied Science). Two
hundred nanograms of 4C template was amplified per reaction. The
primers used for amplification were 59-GGCAGGAAGTTTACAG
GGTTTAACG-39 and 59-TGTGTGTGCTAATGTGTGGACAAGA-39.
The primers were designed within the EcoRI-TaqaI fragment
(chr16:86,542,571–86,543,312), containing part of the Pol II
binding site. The PCR cycling conditions were 30 sec at 94°C,
1 min at 55°C, and 3 min at 68°C. Sixteen reactions were con-
ducted for each template. Pooled PCR products were purified
using the MinElute PCR Purification Kit (QIAGEN).
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As a reference DNA for hybridization, we used uncross-linked
DNA isolated from HPMEC or lymphoblasts with Puregene Blood
Core Kit A, and digested overnight with EcoRI and TaqaI.
Custom-designed 720K microarrays covering 2-Mb regions
flanking FOXF1were designed and produced by Roche-NimbleGen.
Labeling andhybridizationof 4CDNA librarieswere doneaccording
to the manufacturer’s instructions (Roche-NimbleGen). The arrays
were scanned on a NimbleGen 200 Microarray Scanner, and the
datawere analyzed usingNimbleScan v2.5 and SignalMap v1.9. The
4C peak data were generated from the scaled log2 ratio data. Peaks
were detected by searching four or more probes whose signals are
above the specified cutoff values, using a 500-bp sliding window.
Each peak was assigned a false discovery rate (FDR) score. Scores
#0.2 are indicative of an interaction site.
Bisulfite sequencing
Bisulfite modification of lung and blood DNA for sequencing
was performed using the EpiTect Bisulfite Kit (QIAGEN). Primers
for methylation PCR were designed using MethPrimer soft-
ware (http://urogene.org/methprimer/index1.html) (Supplemental
Table S6; Li and Dahiya 2002). PCR was performed in a 25-mL
reaction mixture containing 200 ng of bisulfite-treated DNA,
0.5 nmol of each primer, and 1.25 units of HotStarTaq polymerase
(QIAGEN). The cycling conditions were 1 min at 95°C, 30 sec at
50°C–62°C, and 1 min at 72°C. PCR products ranging from 0.2
to 0.6 kb were purified from unincorporated primers and nucleo-
tides using the QIAquick PCR Purification Kit (QIAGEN), and
T-vector cloned in DH5a cells using the pGEM-T Easy Vector Sys-
tem. Plasmid minipreps were prepared from 25 randomly selected
transformant colonies using the Perfectprep Plasmid Mini Kit
(Eppendorf) and sequenced using T7 and SP6 promoter universal
primers.
In vitro methylation of CpG island
For the in vitro methylation assay, the pUpstdelGliTEasy vector
was first linearized using the SphI restriction nuclease (NEB) and
then treated with HpaII methyltransferase (NEB), which meth-
ylates the internal C residue of the sequence CCGG. The 25-mL
reaction mixture contained 1 mg of the DNA, 1 unit of HpaII
methylase, 50 mM Tris-HCl (pH 7.5), 10 mM EDTA, 5 mM 2-mer-
captoethanol, and 80 mM S-adenosylmethinine. Methylation was
performed for 1 h at 37°C. In the mock-methylation reaction,
S-adenosylmethinine was omitted. Plasmid DNA was subsequently
extractedwith phenol:chlorophorm, precipitatedwith isopropanol,
and analyzed for the degree of methylation by digestion with HpaII
restriction nuclease (NEB). Completely methylated plasmid DNA
was then used for transfections; unmethylated DNA was used as
a control. The stability of methylation following transfection of
themethylated construct was demonstrated recently in the similar
experiments reported by Ilan and Katzav (2012) and Matouskova´
et al. (2006).
Analysis of FOXF1 expression from individual parental
chromosomes
To determine whether there is a difference in FOXF1 expression
from maternal versus paternal chromosomes, we first looked for
heterozygous SNPs in FOXF1 exons in genomic DNA extracted
from normal newborn lung tissue, from which we also extracted
RNA. We identified heterologous SNP G>G/A (chr16:86,547,496)
within FOXF1 exon 2. We then performed two sets of RT-PCR,
using RNA with reverse primer in one setting ending in a G nucle-
otide (FoxE2RnaRG: 59-CAGAAAGTTTACAGTAGAGGTTGGG-39)
and, in the other setting, in anAnucleotide (FoxE2RnaRA: 59-CAGA
AAGTTTACAGTAGAGGTTGGA-39). The forward primer was the
same in both settings (FoxE2RnaF1: 59-GTCTCCCTTTAGAGCCG
TCTTTTG-39). Both pairs of primers were checked for their equal
efficiency in priming PCR using genomic DNA. Semiquantitative
RT-PCR was done using the SuperScript One-Step RT-PCR Kit.
cDNAwas synthesized for 30min at 50°C. The temperature profile
of PCR was 19 cycles of 30 sec at 94°C, 45 sec at 56°C, and 45 sec at
72°C, and a final extension for 5 min at 72°C.
Data access
The aCGH, ChIP-chip, and 4C data sets can be accessed through
the NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.
nlm.nih.gov/geo/) under accession number GSE39258.
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